Log in
Enquire now
‌

US Patent 8906616 Engineering of systems, methods and optimized guide compositions for sequence manipulation

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
89066160
Patent Inventor Names
Fei Ran0
Le Cong0
Patrick Hsu0
Feng Zhang0
Date of Patent
December 9, 2014
0
Patent Application Number
142905750
Date Filed
May 29, 2014
0
Patent Citations Received
‌
US Patent 12123015 Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
0
‌
US Patent 12084676 Cas9 orthologs
0
‌
US Patent 12105089 Cell atlas of the healthy and ulcerative colitis human colon
0
‌
US Patent 12110500 Universal donor stem cells and related methods
0
‌
US Patent 12110545 Methods of assessing nuclease cleavage
0
‌
US Patent 12116619 CRISPR mediated in vivo modeling and genetic screening of tumor growth and metastasis
0
‌
US Patent 12121524 DNA-PK inhibitors
0
‌
US Patent 12123012 Methods and compositions for nucleic acid and protein payload delivery
0
...
Patent Primary Examiner
‌
Ethan C. Whisenant
0
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8906616 Engineering of systems, methods and optimized guide compositions for sequence manipulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.